DE VITA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 25.707
AS - Asia 10.485
EU - Europa 7.850
SA - Sud America 2.256
AF - Africa 194
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 17
AN - Antartide 2
Totale 46.539
Nazione #
US - Stati Uniti d'America 25.354
SG - Singapore 4.958
UA - Ucraina 2.491
CN - Cina 2.281
BR - Brasile 1.911
HK - Hong Kong 1.362
DE - Germania 1.298
IT - Italia 982
VN - Vietnam 690
FI - Finlandia 654
RU - Federazione Russa 616
SE - Svezia 518
IE - Irlanda 477
GB - Regno Unito 328
KR - Corea 257
CA - Canada 226
TR - Turchia 224
IN - India 212
AR - Argentina 125
FR - Francia 103
BD - Bangladesh 87
MX - Messico 78
EC - Ecuador 74
AT - Austria 66
ID - Indonesia 60
PL - Polonia 57
ZA - Sudafrica 57
JP - Giappone 54
IQ - Iraq 50
NL - Olanda 50
IR - Iran 46
ES - Italia 38
MA - Marocco 36
CZ - Repubblica Ceca 33
PY - Paraguay 32
CO - Colombia 28
CL - Cile 27
EU - Europa 27
BE - Belgio 26
PK - Pakistan 25
UZ - Uzbekistan 25
TG - Togo 22
EG - Egitto 21
VE - Venezuela 19
SA - Arabia Saudita 16
UY - Uruguay 16
PE - Perù 15
GR - Grecia 14
LT - Lituania 14
AE - Emirati Arabi Uniti 13
DO - Repubblica Dominicana 13
PT - Portogallo 12
AU - Australia 11
AZ - Azerbaigian 11
CH - Svizzera 11
NP - Nepal 11
TN - Tunisia 11
JO - Giordania 10
RO - Romania 10
BO - Bolivia 9
IL - Israele 9
KE - Kenya 9
KZ - Kazakistan 9
KG - Kirghizistan 8
LB - Libano 8
TT - Trinidad e Tobago 8
AL - Albania 7
HR - Croazia 7
JM - Giamaica 7
CR - Costa Rica 6
DK - Danimarca 6
DZ - Algeria 6
LK - Sri Lanka 6
NO - Norvegia 6
TW - Taiwan 6
AM - Armenia 5
EE - Estonia 5
MY - Malesia 5
NZ - Nuova Zelanda 5
OM - Oman 5
PA - Panama 5
PH - Filippine 5
HN - Honduras 4
KW - Kuwait 4
LV - Lettonia 4
NG - Nigeria 4
PS - Palestinian Territory 4
SN - Senegal 4
AO - Angola 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
BW - Botswana 3
ET - Etiopia 3
GA - Gabon 3
HU - Ungheria 3
RS - Serbia 3
AQ - Antartide 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BF - Burkina Faso 2
Totale 46.501
Città #
Woodbridge 3.780
Ann Arbor 2.593
Fairfield 2.015
Houston 1.974
Singapore 1.875
Jacksonville 1.764
Chandler 1.521
Ashburn 1.467
Hong Kong 1.351
Beijing 1.236
Wilmington 1.003
Dearborn 966
Seattle 712
Boardman 619
Cambridge 616
Dublin 472
Princeton 466
Los Angeles 313
Udine 304
Hefei 254
Seoul 238
Ho Chi Minh City 233
Buffalo 214
Munich 198
Dallas 192
Izmir 191
San Diego 186
São Paulo 166
Redondo Beach 135
Ottawa 130
Hanoi 127
New York 116
Ogden 104
Des Moines 103
Norwalk 92
Helsinki 79
Dong Ket 78
Mumbai 65
Nanjing 59
Nuremberg 59
Redmond 53
Rio de Janeiro 52
Belo Horizonte 50
Trieste 49
Guangzhou 46
London 45
Santa Clara 44
San Mateo 43
Kunming 42
Falls Church 41
Warsaw 37
Milan 36
Brooklyn 34
Montreal 34
Phoenix 34
Tokyo 34
Johannesburg 33
Frankfurt am Main 32
Atlanta 30
Brasília 30
Rome 30
Toronto 30
Guayaquil 29
Salvador 28
Stockholm 28
Turku 28
Augusta 27
Curitiba 27
Brno 26
Chennai 26
Denver 26
Düsseldorf 26
Vienna 26
Brussels 25
Shanghai 25
Simi Valley 25
Andover 24
Quito 24
Da Nang 23
Mexico City 23
Porto Alegre 23
Tashkent 23
Lomé 22
Ribeirão Preto 22
Amsterdam 21
Campinas 21
Haiphong 21
Lauterbourg 21
Leawood 21
Grafing 20
Biên Hòa 19
Boston 19
Lappeenranta 19
Nanchang 19
Recife 19
Thái Bình 18
Washington 18
Wuhan 18
Baghdad 17
Chicago 17
Totale 29.789
Nome #
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. 301
B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: effect of H. Pylori eradication. 188
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 185
Absence of human parvovirus B19 DNA in myoepithelial sialadenitis of primary Sjögren's syndrome. 178
A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: A nationwide multi-center retrospective observational study 177
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients 175
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 173
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 171
Validation of the classification criteria for cryoglobulinaemic vasculitis. 170
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 167
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts 167
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. 164
Efficacy and safety of rituximab in type II mixed cryoglobulinemia. 163
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 163
Terapia dell'artrite reumatoide con immunoglobuline per via endovenosa ad alte dosi: esperienza clinica e revisione della letteratura 162
B-cell lymphomas associated with HCV infection 161
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 160
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 159
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma 158
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 158
Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study 158
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 158
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 157
B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome 156
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 156
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 156
Medical data quality assessment: On the development of an automated framework for medical data curation 156
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 151
Misoprostol-induced urinary incontinence 150
Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma 150
Use of teriparatide in osteoporosis due to active rheumatic diseases 150
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 149
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 148
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome 148
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 148
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 148
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. 146
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 145
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 145
Rituximab for the treatment of type II mixed cryoglobulinemia. 144
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 144
Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue 143
Emerging drugs for primary Sjögren’s syndrome 143
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 142
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 142
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 141
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 141
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 141
Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. 140
BLyS and April serum levels in patients with autoimmune thyroid diseases. 140
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 140
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 140
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 140
Plasmocitoma micromolecolare osteosclerotico 139
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 138
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 138
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 138
SALIVARY GLAND ECHOGRAPHY IN PRIMARY AND SECONDARY SJOGREN'S SYNDROME 137
BLyS Role in the Diagnosis and Prognosis of Neuroendocrine Tumors: Preliminary Results. 137
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 135
B-cell clonality in gastric mucosa of patients with Sjögren's syndrome and connective tissue diseases: relationship with Helicobacter pylori, EBV and human herpesvirus-6 (HHV-6) infections. 134
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 134
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 134
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 134
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 134
Multifocal ischemic necrosis of bone in scleroderma. 133
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. 133
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). 132
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 132
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 132
B cell driving cytokines in eraly rheumatoid arthritis. Assessment of possibile clonal expansions during treatment with cyclosporin A. Arthritis and Rheumatism 1996; 39 (Suppl.): S26. 132
Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. 132
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 132
Subtypes of Epstein-Barr virus in HIV-1-associated and HIV-1-unrelated Hodgkin's disease cases. 132
Treatment of giant cell arteritis with cyclophosphamide pulses 131
General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus 131
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 130
Frequent detection of human herpesvirus 6 DNA in HIV-associated lymphadenopathy. 130
Knuckle pads mimic early psoriatic arthritis 130
Efficacy of selective B cell Blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells 129
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 129
Rarity of microsatellite genomic instability in B-cell non-Hodgkin's lymphomas in hepatitis C virus-infected patients 129
Classification of cryoglobulinemic vasculitis 128
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 128
Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer 127
Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. . 127
Combinad therapy with cyclobenzaprina and ipuprofen in primary fibromialgia sindrome 127
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 127
Leflunomide for active rheumatoid arthritis 126
Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. 126
B-CELL CLONAL EXPANSION IN GASTRIC BIOPSIES OF PATIENTS WITH DYSPEPSIA AND AUTOIMMUNE-DISEASES - EFFECT OF HELICOBACTER-PYLORI ERADICATION 126
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 126
Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. 125
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 125
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 124
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus 124
Dermoscopy in the differential diagnosis between malar rash of systemic lupus erythematosus and erythematotelangiectatic rosacea: an observational study 124
True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. 123
Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome 123
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 123
Totale 14.476
Categoria #
all - tutte 183.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.200 0 0 0 0 0 580 126 529 924 139 663 239
2021/20223.523 89 403 162 380 108 105 156 232 48 532 673 635
2022/20233.839 515 167 69 427 393 1.043 33 287 574 56 114 161
2023/20241.238 179 120 47 26 223 190 51 93 168 67 24 50
2024/20258.740 202 606 300 238 391 413 451 581 931 765 1.402 2.460
2025/20267.742 1.100 1.468 1.293 1.524 2.183 174 0 0 0 0 0 0
Totale 47.449